Abstract:Background: Although breakthroughs have been achieved in gastric cancer (GC) therapy with immune checkpoint inhibitors (ICIs) targeting programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1), the acquisition of high response rate remains a huge challenge for clinicians. It is imperative to identify novel biomarkers for predicting response to immunotherapy and explore alternative therapeutic strategy for GC. Methods: The transcriptomic profiles and clinical information of GC patients from The Cancer Genome Atlas (TCGA)-stomach adenocarcinoma (STAD) database was used to screen differentially expressed lncRNAs between the tumor specimens and the paracancerous tissues. The TargetScan, miRDB and miRcode database were then utilized to construct competing endogenous RNA (ceRNA) networks and identify pivotal lncRNAs. An independent dataset from GEO (GSE70880) and 23 pairs of GC specimens of our cohort were subsequently performed for external validity. The relationship between clinical variables and gene expression were evaluated by Kruskal–wallis test and Wilcoxon signed-rank. The prognostic value of the candidate genes was assessed using Kaplan-Meier analysis and Cox regression models. CIBERSORT and Gene set enrichment analysis (GSEA) were used to determine immune cell infiltration. Gastric adenocarcinoma AGS cells and human embryonic kidney 293T (HEK293T) cells with knockdown of LINC01094 were generated by siRNA transfection, followed by detecting the alteration of the target miRNA and PD-L1/PD-L2 by RT-qPCR. Besides, the interaction between lncRNA and the miRNA–PD-L1/PD-L2 axis were verified by dual luciferase reporter assay. Results: Twenty-two intersecting lncRNAs were identified to be PD-L1/PD-L2-related lncRNAs and LINC01094–miR-17-5p–PD-L1/PD-L2 was constructed as a potential ceRNA network. LINC01094 was increased in tumor specimens than adjacent normal samples and was positively associated with advanced tumor stages and EBV and MSI status. Furthermore, LINC01094 expression was an independent risk factor for poor overall survival (OS) in GC patients. CD8 + T cell exhaustion-related genes were enriched in high-LINC01094 tissues and high-PD-L2 group. A strong positive association of LINC01094 expression was established with M2 macrophages, IL-10 + TAM, as well as PD-L1 and PD-L2 levels, therefore a LINC01094–miR-17-5p–IL-10 network was proposed in macrophages. Using the exoRBase database, LINC01094 was assumed in blood exosomes of GC patients The results of knockdown experiments and luciferase reporter assays revealed that LINC01094 interacted with miR-17-5p and served as a miRNA sponge to regulate the expression of PD-L1 and PD-L2. Conclusion: LINC01094 dually regulates the expression of PD-L1 and PD-L2 and shapes the immunosuppressive tumor microenvironment via sponging miR-17-5p. LINC01094 may serve as a potential prognostic predictor and therapeutic target in GC.

Comprehensive Analysis of Peritoneal Metastasis Sequencing Data to Identify LINC00924 As a Prognostic Biomarker in Gastric Cancer

Overexpression of Lncrna LINC01793 Acts As a Potential Predictor for Progression and Poor Prognosis of Gastric Cancer

LINC00941 Promotes Cell Malignant Behavior and Is One of Five Costimulatory Molecule-Related lncRNAs That Predict Prognosis in Renal Clear Cell Carcinoma

The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer.

LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration

Identification and Experimental Validation of Immune-Associate Lncrnas for Predicting Prognosis in Cervical Cancer

Identification and Validation of Crucial Lnc-Trim28-14 and Hub Genes Promoting Gastric Cancer Peritoneal Metastasis

A pan-cancer analysis of the prognostic value of long non-coding RNA LINC00662 in human cancers

Long Non-coding RNA LINC00941 As a Potential Biomarker Promotes the Proliferation and Metastasis of Gastric Cancer.

Identification of the LNC02362–EFNA5 axis as a Potential Prognosis Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis

Cmar_a_223699 621..631

Upregulation of LINC00659 Expression Predicts a Poor Prognosis and Promotes Migration and Invasion of Gastric Cancer Cells.

The LINC00365/SCGB2A1 (mammaglobin B) Axis Down-Regulates NF-κB Signaling and is Associated with the Progression of Gastric Cancer.

The Prognostic Value of LINC01296 in Pan-Cancers and the Molecular Regulatory Mechanism in Hepatocellular Carcinoma: a Comprehensive Study Based on Data Mining, Bioinformatics, and in Vitro Validation.

Identification of lncRNA dual targeting PD-L1 and PD-L2 as a novel prognostic predictor for gastric cancer

Identification of a 12-LncRNA long Lymph Node Metastasis Prognostic Signature for Cervical Cancer

Linc00483 as ceRNA regulates proliferation and apoptosis through activating MAPKs in gastric cancer.

Comprehensive analysis of immune-related lncRNAs and their clinical relevance in gastric adenocarcinoma

Long non-coding RNA signature for predicting gastric cancer survival based on genomic instability

A Tumor-Specific Prognostic Long Non-Coding RNA Signature in Gastric Cancer.

A novel N7‐methylguanosine‐related long noncoding RNAs signature for predicting prognosis and immune microenvironment in gastric cancer patients